F. Aksu Et Al. , "Chemerin as a marker of subclinical cardiac involvement in psoriatic patients," CARDIOLOGY JOURNAL , vol.24, no.3, pp.276-283, 2017
Aksu, F. Et Al. 2017. Chemerin as a marker of subclinical cardiac involvement in psoriatic patients. CARDIOLOGY JOURNAL , vol.24, no.3 , 276-283.
Aksu, F., ÇALIŞKAN, M., Keles, N., Toprak, A. E., Uzuncakmak, T. K., Kostek, O., ... Yilmaz, Y.(2017). Chemerin as a marker of subclinical cardiac involvement in psoriatic patients. CARDIOLOGY JOURNAL , vol.24, no.3, 276-283.
Aksu, Feyza Et Al. "Chemerin as a marker of subclinical cardiac involvement in psoriatic patients," CARDIOLOGY JOURNAL , vol.24, no.3, 276-283, 2017
Aksu, Feyza Et Al. "Chemerin as a marker of subclinical cardiac involvement in psoriatic patients." CARDIOLOGY JOURNAL , vol.24, no.3, pp.276-283, 2017
Aksu, F. Et Al. (2017) . "Chemerin as a marker of subclinical cardiac involvement in psoriatic patients." CARDIOLOGY JOURNAL , vol.24, no.3, pp.276-283.
@article{article, author={Feyza Aksu Et Al. }, title={Chemerin as a marker of subclinical cardiac involvement in psoriatic patients}, journal={CARDIOLOGY JOURNAL}, year=2017, pages={276-283} }